Merck & Company Inc (MRK) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $119.35
• Market Cap: $305.88B
• P/E Ratio: 16.84
• EPS: $7.27
• Dividend Yield: 0.03%
• 52-Week High: $125.14
• 52-Week Low: $71.26

Market Sentiment

Merck & Company Inc currently has a Bullish sentiment score of 0.22.

About Merck & Company Inc

Merck & Company Inc. is a prominent American multinational pharmaceutical corporation headquartered in Kenilworth, New Jersey, celebrated for its dedication to enhancing global health through cutting-edge pharmaceuticals and vaccines. Established in 1891 as the U.S. subsidiary of the German Merck Group, Merck has a rich history of scientific innovation, focusing on critical therapeutic areas such as oncology, infectious diseases, and cardiovascular health. The company boasts a robust pipeline...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Merck & Company Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is MRK's current dividend yield?

Merck & Company Inc (MRK) has a current dividend yield of 0.03%.

Does MRK pay dividends?

Yes, Merck & Company Inc pays dividends with a current yield of 0.03%.

What is MRK's P/E ratio?

Merck & Company Inc has a price-to-earnings (P/E) ratio of 16.84.

What is MRK's market cap?

Merck & Company Inc (MRK) has a market capitalization of $305.88B with a current stock price of $119.35.